Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Moso

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Open Forum Infectious Diseases|January 29, 2021
Peritoneal Dialysis-Related Peritonitis With Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Vancomycin-Resistant <i>Enterococcus faecium</i>Michael A Moso, Nenad Macesic
Current Opinion in HIV and AIDS|July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV controlMichael A Moso, Michael Roche, Paula M Cevaal, et al.
Current Opinion in Infectious Diseases|October 28, 2022
Clinical and microbiological characteristics of Staphylococcus lugdunensisKatie M Cronin, Michael A Moso, Eddie Chan, et al.
Current HIV/AIDS Reports|June 16, 2025
An Update on the Clinical Management of HIV and Tuberculosis Co-Infection in Pregnancy: TB Preventative Therapy, Long-Acting ARVs, and Bedaquiline-Based RegimensTim Crocker-Buque, Michael A Moso, Justin T Denholm, et al.
International Journal of STD & AIDS|August 18, 2018
Treatment of disseminated histoplasmosis in advanced HIV using itraconazole with increased bioavailabilityRekha P Mangalore, Michael A Moso, Katie Cronin, et al.
Pathology|February 26, 2023
Reducing time to new HIV diagnosis: time for change in the HIV diagnostic algorithm?Michael A Moso, Eloise Williams, Kasha P Singh, et al.
The Lancet. Infectious Diseases|September 18, 2023
Prevention and post-exposure management of occupational exposure to Ebola virusMichael A Moso, Chuan K Lim, Eloise Williams, et al.
Clinical Microbiology Reviews|August 29, 2025
A review of post-exposure strategies for high-consequence viral pathogens in the laboratoryGrace Butel-Simoes, Michael A Moso, Prashanth Ramachandran, et al.
Internal Medicine Journal|March 17, 2023
Survey of treatment practices for immunocompromised patients with COVID-19 in AustralasiaMichael A Moso, Joe Sasadeusz, Catherine O Morrissey, et al.
Current Opinion in HIV and AIDS|November 21, 2025
Immunotherapy and impact on tissue reservoirsHannah A D King, Thomas A Angelovich, Michael A Moso, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Open Forum Infectious Diseases|January 29, 2021
Peritoneal Dialysis-Related Peritonitis With Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Vancomycin-Resistant <i>Enterococcus faecium</i>Michael A Moso, Nenad Macesic
Current Opinion in HIV and AIDS|July 19, 2025
CRISPR/Cas9 for achieving postintervention HIV controlMichael A Moso, Michael Roche, Paula M Cevaal, et al.
Current Opinion in Infectious Diseases|October 28, 2022
Clinical and microbiological characteristics of Staphylococcus lugdunensisKatie M Cronin, Michael A Moso, Eddie Chan, et al.
Current HIV/AIDS Reports|June 16, 2025
An Update on the Clinical Management of HIV and Tuberculosis Co-Infection in Pregnancy: TB Preventative Therapy, Long-Acting ARVs, and Bedaquiline-Based RegimensTim Crocker-Buque, Michael A Moso, Justin T Denholm, et al.
International Journal of STD & AIDS|August 18, 2018
Treatment of disseminated histoplasmosis in advanced HIV using itraconazole with increased bioavailabilityRekha P Mangalore, Michael A Moso, Katie Cronin, et al.
Pathology|February 26, 2023
Reducing time to new HIV diagnosis: time for change in the HIV diagnostic algorithm?Michael A Moso, Eloise Williams, Kasha P Singh, et al.
The Lancet. Infectious Diseases|September 18, 2023
Prevention and post-exposure management of occupational exposure to Ebola virusMichael A Moso, Chuan K Lim, Eloise Williams, et al.
Clinical Microbiology Reviews|August 29, 2025
A review of post-exposure strategies for high-consequence viral pathogens in the laboratoryGrace Butel-Simoes, Michael A Moso, Prashanth Ramachandran, et al.
Internal Medicine Journal|March 17, 2023
Survey of treatment practices for immunocompromised patients with COVID-19 in AustralasiaMichael A Moso, Joe Sasadeusz, Catherine O Morrissey, et al.
Current Opinion in HIV and AIDS|November 21, 2025
Immunotherapy and impact on tissue reservoirsHannah A D King, Thomas A Angelovich, Michael A Moso, et al.
Pageof 2